Acquistions

AbbVie Acquires Allergan

Global biopharmaceutical company AbbVie has completed its acquisition of Allergan. The acquisition significantly expands and diversifies AbbVie’s product portfolio, which currently includes Humira, Skyrizi and Rinvoq under its Immunology umbrella, and Hematologic Oncology brands Imbruvica and Venclexta.